会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • TISSUE TRANSPLANTATION COMPOSITIONS AND METHODS
    • 组织移植组合物和方法
    • WO2008008814A2
    • 2008-01-17
    • PCT/US2007073225
    • 2007-07-11
    • FERREE BRET A
    • FERREE BRET A
    • A61F2/02A61F2/44A61K35/12A61K35/30A61K35/32A61K48/00A61P43/00
    • A61L27/38A61F2/442A61F2002/444A61F2002/4445A61F2002/445A61K35/15A61K35/19A61K35/28A61K35/32A61K35/33A61L27/3612A61L27/3654A61L27/3658A61L27/3687A61L27/3695C12N5/0655C12N2509/00
    • A biomedical material for transplant to a subject is provided according to embodiments of the present invention which includes an isolated donor tissue enzyme-treated to reduce the amount of proteoglycans in the donor tissue compared to untreated tissue. Isolated cells are optionally added to the enzyme-treated donor tissue, including leukocytes, particularly monocytes; macrophages; platelets; cells derived from an intervertebral disc such as chondrocyte-like nucleus pulposus cells; fibrocytes; fibroblasts; mesenchymal stem cells; mesenchymal precursor cells; chondrocytes; or a combination of any of these. The isolated donor tissue is articular cartilage or an intervertebral disc tissue such as nucleus pulposus tissue and/or annulus fibrosis tissue enzyme-treated to remove proteoglycans normally present in these tissues. A biomedical material of the present invention is administered to a subject to treat a disorder or injury, such as a disorder or injury to connective tissue.
    • 根据本发明的实施方案提供了用于移植到受试者的生物医学材料,其包括经处理的分离的供体组织,以与未处理的组织相比减少供体组织中的蛋白聚糖的量。 分离的细胞任选加入酶处理的供体组织中,包括白细胞,特别是单核细胞; 巨噬细胞; 血小板; 衍生自椎间盘的细胞如软骨细胞样髓核细胞; 成纤维细胞; 成纤维细胞; 间充质干细胞; 间充质前体细胞; 软骨细胞; 或任何这些的组合。 分离的供体组织是关节软骨或椎间盘组织,例如髓核组织和/或环状纤维化组织酶处理以去除通常存在于这些组织中的蛋白聚糖。 将本发明的生物医学材料施用于受试者以治疗病症或损伤,例如结缔组织的病症或损伤。